Hypertrophic Cardiomyopathy Webinars

Date: Thursday, July 14, 2022
Time: 1:00 p.m. CDT to 2:00 p.m. CDT

Amplifying the voices of those living with HCM, this roundtable will highlight individual experiences related to symptom onset, diagnosis, symptom management, support from healthcare professionals, and describe the impact of hypertrophic cardiomyopathy on daily life. Leading experts in HCM will provide actionable steps the care team can take in providing the best guideline directed care.

In this series of lightning talks, seven leading experts will tackle case studies and explore the complexities of HCM diagnosis, management, and treatment. Each case study will highlight aspects of the varied HCM patient journey and pursuit of accurate diagnosis. With your help HCM patients may see better outcomes.

Presenters: Anjali Tiku Owens, MD; Richard Bach, MD, FAHA, FACC, FSCAI
Moderator: James E. Udelson, MD, FAHA

Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn the latest in the clinical management of HCM in this free webinar.

Presenters: Matthew Martinez, MD, FACC; Anjali Tiku Owens, MD; Sharon Cresci, MD, FAHA, FACC, FASE
Moderator: James E. Udelson, MD, FAHA

HCM is a chronic disease that can progress to cardiac dysfunction and the clinical syndrome of heart failure. It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Which of your patients is undiagnosed?

Presenters: Martin S. Maron, MD; Marye Gleva, MD
Moderator: James E. Udelson, MD, FAHA

Some people with HCM are at increased risk for developing atrial fibrillation, heart failure, suffering from stroke and even sudden cardiac death (SCD). Patients who suffer from arrhythmias associated with HCM may require implantable cardioverter-defibrillator devices to reduce their risk of SCD. Join Drs. Maron, Gleva, and Udelson as they discuss risk stratification strategies, device selection, and the role of shared decision-making in the prevention of SCD.

Presenters: Theodore Abraham, MD; Ethan Rowin, MD
Moderator: James E. Udelson, MD, FAHA

Hypertrophic cardiomyopathy is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Diagnosis is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart.

Viewers will learn about the role of imaging in the diagnosis and treatment of patients with HCM.

Presenters: Dr. Anjali Owens, Dr. Sharon Cresci
Moderator: Dr. James Udelson

Summary: It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Which of your patients is undiagnosed? Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age. HCM can be a debilitating and life-changing disease. People with HCM are often forced to make lifestyle changes, such as limiting their activity, to accommodate their disease. Sometimes this accommodation might not even be noticed by the patient themselves meaning careful questioning of symptoms and changes in activity are critical.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Presenters: Dr. Sharon Cresci, Dr. Robert Fraser
Moderator: Dr. James Udelson

Summary: Hypertrophic cardiomyopathy or HCM is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Some people with HCM experience symptoms such as fatigue, fainting, shortness of breath, chest pain or palpitations. Others with HCM do not experience any symptoms. Listen to experts as they explore the HCM symptoms, epidemiology, pathophysiology and the burden of the disease on patients and families.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.